From Mobile Phones to Medical Solutions: Leadership on Transformation in the Age of AI

In an exclusive television interview with TVB News (Hong Kong), our CEO Danny Sit and Chief Sales Officer John Murtha discussed how shifting market demands, AI innovation, and the lessons of the pandemic accelerated our move into regulated medical mobility.

Watch the full interview below to hear directly from our leadership team.

Artificial intelligence is no longer a future promise — it is actively reshaping how manufacturers design products, choose markets, and define their long-term roles in the technology ecosystem.

At this year’s CES, that shift was impossible to miss.

Even before the official opening, industry leaders gathered to exchange views on where innovation is heading. Organizers observed a sharp rise in AI-driven and metaverse-related products compared with previous years. At the same time, analysts pointed to explosive growth ahead in digital health, with projections that the global mobile medical device market could exceed $700 billion within the next decade.

For our CEO Danny Sit, those numbers confirm a reality he has been navigating for years: adapt or be left behind.

A Pandemic That Accelerated Change

When COVID-19 disrupted global markets, companies rooted in traditional consumer electronics suddenly faced enormous uncertainty.

NUU’s business model, long known for SIM-unlocked smartphones in the U.S., felt the impact immediately.

But where many saw contraction, Danny saw a doorway.

Lockdowns made hospital visits difficult. Patients still needed consultations, monitoring, and treatment. Healthcare providers urgently required secure, reliable mobile platforms that could travel with the patient.

“Mobile devices became the bridge between doctors and people at home,” Danny explained.

That demand sparked a transformation beginning in 2020 — one that pushed the company far beyond retail mobility and into regulated medical environments.

From Smartphone to Certified Medical Tool

Instead of flashy consumer demos on the main show floor, Danny chose to present something different at CES: a purpose-built medical phone designed to support diabetes treatment.

The product was introduced within the booth of strategic chip partner MediaTek, emphasizing the deep technical collaboration required to make healthcare mobility possible.

Our CSO John Murtha described the model clearly.

“We work with medical technology companies that need a stable, dedicated Android™ device inside hospitals and clinical programs. Reliability matters more than entertainment features.”

The system connects to a continuous glucose monitor worn on the body. Data flows to the phone, which communicates with an insulin pump to automate dosing — reducing or even eliminating routine injections.

However, turning a handset into a medical device is far from simple.

It requires:

• meeting strict regulatory pathways such as FDA and IEC frameworks
  
• validating component stability
  
• ensuring cybersecurity readiness
  
• guaranteeing dependable wireless performance
  

With MediaTek’s chipset platform, the team optimized Bluetooth behavior to maintain uninterrupted communication between sensor and device throughout the day.

A Different Kind of Product Strategy

Medical mobility does not compete on the same terms as consumer electronics.

There is no race for better gaming performance or cinematic photography. Instead, devices are engineered for:

✔ consistency
✔ longevity
✔ controlled environments
✔ affordability at scale

Because the phone is designed for a focused application, manufacturers can avoid expensive flagship components. John noted that many healthcare deployments target wholesale price levels below $200, making broad distribution economically viable.

The value is not in luxury features — it is in dependable outcomes.

Transformation Is Now a Requirement

CES demonstrated that AI, connectivity, and vertical specialization are rewriting the expectations placed on hardware companies.

For Danny, the lesson is straightforward.

“Manufacturers must rethink what business they are truly in. If we help deliver care, improve monitoring, and support treatment, then we are part of healthcare infrastructure.”

That identity demands higher standards, deeper partnerships, and a long-term commitment to customers whose missions extend far beyond technology.

Looking Forward

As remote care expands and intelligent systems become central to medicine, opportunities will grow for partners able to merge agile engineering with regulatory discipline.

For leaders like Danny and John, the future is not about chasing trends.

It is about building platforms others can trust with human lives. Ready to build on a stronger foundation?
Talk with our team about how our global production model and deep ecosystem partnerships power secure, scalable Android™ solutions for healthcare and regulated industries. We are your partner in custom-built Android™ devices and software.